Cwm, LLC Pep Gen Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Pep Gen Inc. stock. As of the latest transaction made, Cwm, LLC holds 16 shares of PEPG stock, worth $23. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 2 700.0%

Holding current value

$23

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$7.75 - $18.55 $108 - $259	14 Added 700.0%	16 $0
Q2 2024 Jul 09, 2024	BUY	$10.54 - $18.14 $10 - $18	1 Added 100.0%	2 $0
Q1 2024 Apr 05, 2024	BUY	$6.63 - $17.3 $6 - $17	1 New	1 $0

Others Institutions Holding PEPG

# of Institutions

Shares Held

25.2M

Call Options Held

Put Options Held

Ra Capital Management, L.P. Boston, MA

10.7M
Shares

$15.4 Million
1.27% of portfolio
Janus Henderson Group PLC London, X0

2.34M
Shares

$3.36 Million
0.01% of portfolio
Suvretta Capital Management, LLC New York, NY

1.66M
Shares

$2.39 Million
0.56% of portfolio
Viking Global Investors LP

1.48M
Shares

$2.13 Million
0.05% of portfolio
Perceptive Advisors LLC New York, NY

1.41M
Shares

$2.03 Million
0.32% of portfolio

View Full List

About PepGen Inc.

Ticker PEPG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,631,900
Market Cap $34M
Description
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...

More about PEPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account